Private Equity

The climate for buyouts and acquisitions is constantly changing, demanding a high degree of tax and financial literacy, a commercial negotiating style and market sector expertise. Goodwin consistently answers those challenges, making it one of the premier M&A practices in the United States, with a robust focus on the middle market. And with the breakneck pace of technology disrupting industries around the world, we have a team that is equally proficient in advising the innovators and the investors across the private equity, technology, healthcare and life sciences sectors. We partner with clients to embrace the promise and potential of innovation to make a lasting impact.

Our group consists of more than 100 corporate M&A attorneys and professional staff with significant and substantive expertise and hands-on experience in structuring complex mergers and acquisitions, divestitures, joint ventures, spinoffs and tender offers. 

The ongoing convergence of capital and innovation requires advisors who are fluent in both worlds. At Goodwin, we have a global team that we believe is unique in BigLaw – a team that is equally proficient in advising the innovators and the investors across the technology, life sciences, real estate, private equity, and financial industries. Companies seeking to grow, increase liquidity for their investors or reduce their cost of capital regularly turn to Goodwin. We have one of the most active capital markets and public company practices in the United States, serving as outside counsel to public companies in a range of industries and who are listed on both U.S. and non-U.S. exchanges. We combine deep industry knowledge with broad technical expertise across all equity and debt securities and alternative investment structures. Since 2010, we have advised clients in more than 600 public offerings for over $145 billion in equity proceeds. We are consistently recognized by industry publications as one of the most active and innovative advisers for capital markets transactions and public companies.

Goodwin’s unique combination of deep experience serving both the innovators and investors in a rapidly-changing, technology-driven economy sets us apart. We partner with clients to embrace the promise and potential of innovation to make a lasting impact. Our Debt Finance practice represents borrowers, private equity sponsors and lenders in a broad range of financing transactions. Our Debt Finance lawyers work closely with the firm's Private Equity, Technology Companies, Capital Markets, and Financial Restructuring groups structuring, negotiating and documenting domestic and cross-border debt financing arrangements, including secured and unsecured senior, mezzanine and subordinated debt facilities, acquisition-financing transactions, working capital facilities, as well as loan workouts and restructurings.

On the borrower side, Goodwin represents private equity firms and their portfolio companies, leading public and private companies and start-ups in a wide variety of business industries. On the lender side, Goodwin’s clients include domestic and international banks, insurance and finance companies, mezzanine lenders, business development companies and other institutional investors.

Technology has permeated the modern age and influences nearly every aspect of our daily lives. Long-standing financial services institutions are a prime example of how far the technological revolution has reached. Brick and mortar financial institutions are facing new disruptive competitors in everything ranging from mobile and peer-to-peer payments to online banking and lending. Fintech companies are receiving record high investments across the globe and the market is thriving at an unparalleled pace. With new regulatory considerations developing in tandem, it is crucial for a successful Fintech company to have expert legal counsel that is fully apprised of all the newest developments, such as GDPR in Europe, and how they affect the industry.

Succeeding in the life sciences industry is as much about strategy and execution as it is about research and development. And with the breakneck pace of technology disrupting industries around the world, Goodwin’s depth of experience not only in the life sciences space, but also in collaboration with our technology, healthcare and private equity lawyers, makes our team exceptionally suited to address whatever the future brings. We partner with clients to embrace the promise and potential of innovation to make a profound and lasting impact.

Lawyers in our life sciences practice are deeply experienced in corporate governance, financing and M&A transactions, collaborations and licensing, regulatory matters, and intellectual property law. We understand the challenges of securing funding, safeguarding intellectual property, establishing partnerships, bringing new products to market, opening up new revenue streams, and protecting existing product lines. As part of our interdisciplinary approach, we collaborate with attorneys in our patent litigation, products litigation, privacy and cybersecurity, employment and tax practices to protect client interests and to advocate on their behalf.

With a full service team of highly experienced lawyers resident in key life sciences hubs, our team helps clients find the strategic paths that foster growth and minimize risk across all phases of the corporate life cycle. Motivated by the knowledge that the work that we do with you is improving people’s lives, we serve as an extension of your team so you can focus on your core business.

Few firms offer the breadth of practice that we bring to private fund managers and investors. We understand the issues specific to different types of funds and offer advice that comes from a wealth of experience across industries and global markets. Our lawyers work in all the key industries, including, real estate, venture capital, private equity, infrastructure, natural resources and hedge funds, raising funds worldwide that range from less than $50 million to over $17 billion. And with the breakneck pace of technology disrupting industries around the world, we have a team that is equally proficient in advising the innovators and the investors across the private equity, technology, healthcare and life sciences sectors. We partner with clients to embrace the promise and potential of innovation to make a lasting impact.

The depth and breadth of our experience allows us to provide our clients with the most current market terms for their industry as well as access to cutting-edge developments across industries. We handle every stage in the life cycle, and we provide fund managers with the sophisticated level of counsel required for forming, advising and operating private investment funds. Within fund formation, we take a creative approach, starting with not only the specific objectives of a particular fund but also an assessment of how the fund fits within the client’s broader business goals. We then help fund managers determine the best structure and terms to achieve those goals.

As a growing technology company, your prospects are exciting and your challenges are unique – from securing funding, protecting IP, and navigating the regulatory environment, to differentiating yourself in the marketplace, managing customer acquisition and scaling your business. We get it. Our dedicated team brings a comprehensive, coordinated approach that interconnects business, new technologies and the law. Our depth of experience in the private equity space along with our technology, healthcare and life sciences lawyers makes Goodwin uniquely suited to harness the breakneck pace of technology. We partner with clients to embrace the promise and potential of innovation to make a profound and lasting impact.

Goodwin’s greater China team of multilingual lawyers qualified in the PRC, UK, Hong Kong, and the U.S. offers skilled cross-border legal advice within a broad range of sectors and practice areas.

Our comprehensive China practice is focused on capital markets and securities (U.S. listings, GEM and H-shares or capital raisings), mergers and acquisitions, joint ventures and strategic transactions, private equity, venture capital, fund formation, hospitality and real estate, and regulatory compliance. With the breakneck pace of technology disrupting industries around the world, we partner with our clients and embrace the promise and potential of innovation to make a lasting impact. More broadly, Goodwin has a global team that we believe is unique in BigLaw – a team that is equally proficient in advising the innovators and the investors across the private equity, technology, real estate, healthcare and life sciences sectors.

As businesses today face an increasingly sophisticated threat environment compounded by aggressive regulatory enforcement, companies need a partner who can help mitigate risk and respond to the unthinkable. Our Legal 500 and Chambers ranked Privacy + Cybersecurity practice is one of the longest-standing of any AmLaw 50 firm. Dating back to the late 1990s and established formally in 2004, our practice is fully integrated and leverages the firm's core strengths, with the group's lawyers coming from our technology, financial institutions, licensing, litigation, regulatory and appellate practices. Our unique approach, focusing on client needs and value, enables us to engage specialists whose experience is framed by a holistic understanding of clients' greatest risks in this threatening environment.

Workouts. Reorganization. Liquidation.

From troubled companies and international insolvencies to failed start-ups, we work with debtors, creditors and committees in high profile and middle-market restructurings.

Goodwin has one of the largest and most active practices in the country defending securities class action, shareholder derivative, and other shareholder litigation, SEC investigations and enforcement proceedings, and related litigation and regulatory matters. At any given time, we are handling matters all across the country as well as for internationally based clients. We are currently defending clients in some of the most prominent cases in the country arising out of the subprime mortgage crisis.